ITDts is a novel selective TGF-β pathway-selective inhibitor that inhibits TGF-β activity by selectively degrading the TGF-β2 receptor at the proteosome level. Racemic ITDts is 2-fold selective over the closely related Activin A signaling pathway. ITDts stimulates embryonic stem cells to differentiate into cardiomyocytes (IC50 0.7 µM) by degrading the receptor and inhibiting intracellular signaling. ITDts has been formulated as a salt to increase stability and improve water solubility (~0.1 mg/mL) for ease of handling. As a salt, ITDts is chemically and metabolically stable and is non-cytotoxic. ITDts can be used to study a wide range of biological questions in cellular processing and TGF-β signaling.
Technical information:
Chemical Formula: | C27H26F3NO3 | |
CAS #: | N/A | |
Molecular Weight: | 469.50 | |
Purity: | >98% | |
Appearance: | Yellow solid | |
Chemical Name: | methyl 2,7,7-trimethyl-5-oxo-4-(4"-(trifluoromethyl)-[1,1"-biphenyl]-4-yl)-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate | |
Solubility: | Up to 50 mM in DMSO |
Shipping Condition: The product is shipped in a glass vial at ambient temperature.Storage: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.
Reference:
1. | Willems E, et al. Small molecule-mediated TGF-β type II receptor degradation promotes cardiomyogenesis in embryonic stem cells. Cell Stem Cell. 2012;11(2):242-52. PMID: 22862949 |
Other Information:
Product Specification (pdf)MSDS (pdf)
Cellagen利用广泛的研究以及我们在干细胞生物学,药物化学和产品开发方面的专业知识,Cellagen长期以来一直为专业OEM产品提供世界领先的公司,为一线干细胞研究奠定了基础。
现在,Cellagen扩展了其最佳产品系列,并直接向研究界提供。Cellagen与世界领先的科学家有着密切的联系,并且始终认识到高标准科学研究的未满足需求。